The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

This article is part of an ongoing series of stories by ICT examining the complicated issues of Indigenous identity.

Lawmakers have passed a bill to strengthen Illinois’ ability to make its own vaccine guidelines — legislation that follows ...